Successful Management of Massive Intraperitoneal Bleeding in a Hemophilia A Patient with Inhibitor by Surgical Debridement of the Incomplete Hematoma and Administration of Recombinant Factor VIII and Activated Factor VII

Publisher： Karger

E-ISSN： 1424-8840|35|5|405-407

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.35, Iss.5, 2007-01, pp. : 405-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 967-977

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios

By McClelland Shearwood   Won Eun   Lam Cornelius  

Neurocritical Care, Vol. 7, Iss. 2, 2007-10 ,pp. : 136-139

Humana Press, Inc

Access to resources Recommend Favorite

A Single Dose of Recombinant Activated Factor VII (NovoSeven®) Did Not Impair the Function of the Coronary Artery Bypass Grafts – Successful Treatment of Critical Bleeding after Cardiac Surgery in Two Cases

By  

Transfusion Medicine and Hemotherapy, Vol. 34, Iss. 3, 2007-05 ,pp. : 204-207

Karger

Access to resources Recommend Favorite

Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 162-163

Karger

Access to resources Recommend Favorite